{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:06:26Z","timestamp":1760187986619,"version":"3.41.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.1023\/a:1005768910871","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T23:13:52Z","timestamp":1040512432000},"page":"17-23","source":"Crossref","is-referenced-by-count":36,"title":["P16 deletion and mutation analysis in human brain tumors"],"prefix":"10.1007","volume":"31","author":[{"given":"Fred G.","family":"Barker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengchin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Furman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken D.","family":"Aldape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.B.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"112038_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gcc.2870090107","volume":"9","author":"MJ Bello","year":"1994","unstructured":"Bello MJ, de Campos JM, Vaquero J, Kusak ME, Sarasa JL, Pestana A, Rey JA: Molecular and cytogenetic analysis of chromosome 9 deletions in 75 malignant gliomas. Genes Chromosom Cancer 9: 33\u201341, 1994","journal-title":"Genes Chromosom Cancer"},{"key":"112038_CR2","first-page":"344","volume":"54","author":"A Coleman","year":"1994","unstructured":"Coleman A, Fountain JW, Nobori T, Olopade OI, Robertson G, Housman DE, Lugo TG: Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia. Cancer Res 54: 344\u2013348, 1994","journal-title":"Cancer Res"},{"key":"112038_CR3","first-page":"3674","volume":"53","author":"CD James","year":"1993","unstructured":"James CD, He J, Collins VP, Allalunis-Turner MJ, Day RS 3rd: Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group. Cancer Res 53: 3674\u20133676, 1993","journal-title":"Cancer Res"},{"key":"112038_CR4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","volume":"366","author":"M Serrano","year":"1993","unstructured":"Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/ CDK4. Nature 366: 704\u2013707, 1993","journal-title":"Nature"},{"key":"112038_CR5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","volume":"264","author":"A Kamb","year":"1994","unstructured":"Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS 3rd, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436\u2013440, 1994","journal-title":"Science"},{"key":"112038_CR6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/368753a0","volume":"368","author":"T Nobori","year":"1994","unstructured":"Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753\u2013756, 1994","journal-title":"Nature"},{"key":"112038_CR7","first-page":"328","volume":"36","author":"MK Nicholas","year":"1994","unstructured":"Nicholas MK, Stadler WM, Olopade O: Detection of loss of allelic heterozygosity on human chromosome 9p in gliomas (Abstract). Ann Neurol 36: 328, 1994","journal-title":"Ann Neurol"},{"key":"112038_CR8","first-page":"5262","volume":"54","author":"L Xu","year":"1994","unstructured":"Xu L, Sgroi D, Sterner CJ, Beauchamp RL, Pinney DM, Keel S, Ueki K, Rutter JL, Buckler AJ, Louis DN, Gusella JF, Ramesh V: Mutational analysis of CDKN2 (MTS1\/p16-ink4) in human breast carcinomas. Cancer Res 54: 5262\u20135264, 1994","journal-title":"Cancer Res"},{"key":"112038_CR9","first-page":"5269","volume":"54","author":"M Ohta","year":"1994","unstructured":"Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CL, Croce CM, Huebner K: Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res 54: 5269\u20135272, 1994","journal-title":"Cancer Res"},{"key":"112038_CR10","first-page":"5050","volume":"54","author":"S-Y Zhang","year":"1994","unstructured":"Zhang S-Y, Klein-Szanto AJP, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA, Goodrow TL: Higher frequency of alterations in the p16\/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 54: 5050\u20135053, 1994","journal-title":"Cancer Res"},{"key":"112038_CR11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0165-4608(94)00213-U","volume":"82","author":"P Chen","year":"1995","unstructured":"Chen P, Iavarone A, Fick J, Edwards M, Prados M, Israel MA: Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet Cytogenet 82: 106\u2013115, 1995","journal-title":"Cancer Genet Cytogenet"},{"key":"112038_CR12","first-page":"20","volume":"55","author":"DG Walker","year":"1995","unstructured":"Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M: Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 55: 20\u201323, 1995","journal-title":"Cancer Res"},{"key":"112038_CR13","first-page":"5804","volume":"54","author":"J He","year":"1994","unstructured":"He J, Allen JR, Collins VP, Allalunis-Turner MJ, Godbout R, Day RS 3rd, James CD: CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 54: 5804\u20135807, 1994","journal-title":"Cancer Res"},{"key":"112038_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","volume":"8","author":"CJ Hussussian","year":"1994","unstructured":"Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH Jr., Tucker MA, Dracopoli NC: Germline p16 mutations in familial melanoma. Nature Genetics 8: 15\u201321, 1994","journal-title":"Nature Genetics"},{"key":"112038_CR15","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/hmg\/3.10.1841","volume":"3","author":"K Ueki","year":"1994","unstructured":"Ueki K, Rubio M-P, Ramesh V, Correa KM, Rutter JL, von Deimling A, Buckler AJ, Gusella JF, Louis DN: MTS1\/ CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Molec Genet 3: 1841\u20131845, 1994","journal-title":"Hum Molec Genet"},{"key":"112038_CR16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0168-9525(00)89027-7","volume":"11","author":"A Kamb","year":"1995","unstructured":"Kamb A: Cell-cycle regulators and cancer. Trends Genet 11: 136\u2013140, 1995","journal-title":"Trends Genet"},{"key":"112038_CR17","first-page":"1351","volume":"55","author":"W Arap","year":"1995","unstructured":"Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang HJS: Replacement of the p16\/CDKN2 gene suppresses human glioma cell growth. Cancer Res 55: 1351\u20131354, 1995","journal-title":"Cancer Res"},{"key":"112038_CR18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.8023167","volume":"265","author":"P Cairns","year":"1994","unstructured":"Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D: Rates of p16 (MTS1) mutations in primary tumors with 9p loss (letter). Science 265: 415\u2013417, 1994","journal-title":"Science"},{"key":"112038_CR19","first-page":"6338","volume":"54","author":"C Giani","year":"1994","unstructured":"Giani C, Finocchiaro G: Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res 54: 6338\u20136339, 1994","journal-title":"Cancer Res"},{"key":"112038_CR20","first-page":"6321","volume":"54","author":"EE Schmidt","year":"1994","unstructured":"Schmidt EE, Ichimura K, Reifenberger G, Collins VP: CDKN2 (p16\/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54: 6321\u20136324, 1994","journal-title":"Cancer Res"},{"key":"112038_CR21","first-page":"6353","volume":"54","author":"J Jen","year":"1994","unstructured":"Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B: Deletion of p16 and p15 genes in brain tumors. Cancer Res 54: 6353\u20136358, 1994","journal-title":"Cancer Res"},{"key":"112038_CR22","first-page":"613","volume":"146","author":"T Moulton","year":"1995","unstructured":"Moulton T, Samara G, Chung W-Y, Yuan L, Desai R, Sisti M, Bruce J, Tycko B: MTS1\/p16\/CDKN2 lesions in primary glioblastoma multiforme. Am J Pathol 146: 613\u2013619, 1995","journal-title":"Am J Pathol"},{"key":"112038_CR23","first-page":"581","volume":"36","author":"LS Rao","year":"1995","unstructured":"Rao LS, Newcomb EW: Infrequent p16\/CDKN2 gene mutations in human primary astrocytic and non-astrocytic brain tumors. Proc AACR 36: 581, 1995 (abstract)","journal-title":"Proc AACR"},{"key":"112038_CR24","first-page":"1941","volume":"55","author":"R Nishikawa","year":"1995","unstructured":"Nishikawa R, Furnari FB, Lin H, Arap W, Berger MS, Cavenee WK, Huang H-JS: Loss of p16INK4 expression is frequent in high grade gliomas. Cancer Res 55: 1941\u20131945, 1995","journal-title":"Cancer Res"},{"key":"112038_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ng0795-351","volume":"10","author":"NA Gruis","year":"1995","unstructured":"Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A, Bergman W, Frants RR: Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 10: 351\u2013353, 1995","journal-title":"Nat Genet"},{"key":"112038_CR26","first-page":"3375","volume":"9","author":"GA Otterson","year":"1994","unstructured":"Otterson GA, Kratzke RA, Coxon A, Kim YW, Kaye FJ: Absence of p16-INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9: 3375\u20133378, 1994","journal-title":"Oncogene"},{"key":"112038_CR27","first-page":"505","volume":"55","author":"GI Shapiro","year":"1995","unstructured":"Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richards W, Sugarbaker DJ, Rollins BJ: Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res 55: 505\u2013509, 1995","journal-title":"Cancer Res"},{"key":"112038_CR28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ijc.2910610120","volume":"61","author":"L Aagaard","year":"1995","unstructured":"Aagaard L, Lukas J, Bartkova J, Kjerulff AA, Strauss M, Bartek J: Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur on distinct sub-sets of human cancer cell lines. Int J Cancer 61: 115\u2013120, 1995","journal-title":"Int J Cancer"},{"key":"112038_CR29","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jnci\/87.10.756","volume":"87","author":"MJ Kelley","year":"1995","unstructured":"Kelley MJ, Nakagawa K, Steinberg SM, Mulshine JL, Kamb A, Johnson BE: Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. J Natl Cancer Inst 87: 756\u2013761, 1995","journal-title":"J Natl Cancer Inst"},{"key":"112038_CR30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410360505","volume":"36","author":"JW Henson","year":"1994","unstructured":"Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbenderr F, Xu H-J, Benedict WF, Yandell DW, Louis DN: The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36: 714\u2013721, 1994","journal-title":"Ann Neurol"},{"key":"112038_CR31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF01324703","volume":"16","author":"W Hamel","year":"1993","unstructured":"Hamel W, Westphal M, Shepard HM: Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease. J Neurooncol 16: 159\u2013165, 1993","journal-title":"J Neurooncol"},{"key":"112038_CR32","first-page":"445","volume":"6","author":"DJ Venter","year":"1991","unstructured":"Venter DJ, Bevan KL, Ludwig RL, Riley TE, Jat PS, Thomas DG, Noble MD: Retinoblastoma gene deletions in human glioblastomas. Oncogene 6: 445\u2013448, 1991","journal-title":"Oncogene"},{"key":"112038_CR33","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1227\/00006123-199505000-00013","volume":"36","author":"C Raffel","year":"1995","unstructured":"Raffel C, Ueki K, Harsh GR 4th, Louis DN: The multiple tumor suppressor 1\/cyclin-dependent kinase inhibitor 2 gene in human central nervous system primitive neuroectodermal tumor. Neurosurgery 36: 971\u2013975, 1995","journal-title":"Neurosurgery"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005768910871.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1005768910871\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005768910871.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T08:42:50Z","timestamp":1749631370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1005768910871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["112038"],"URL":"https:\/\/doi.org\/10.1023\/a:1005768910871","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}